Literature DB >> 8390316

Superselective transcatheter arterial embolization with ethanol and iodized oil for hepatocellular carcinoma.

J H Park1, J K Han, J W Chung, B I Choi, M C Han, Y I Kim.   

Abstract

PURPOSE: The effectiveness of superselective transcatheter arterial embolization with a mixture of ethanol and iodized oil was evaluated for hepatocellular carcinoma. PATIENTS AND METHODS: The procedure was attempted in 14 male patients with hepatocellular carcinoma. The tumor was a single small (2-5 cm in diameter) hypervascular nodule in all patients, except in one patient with two nodules. Superselective catheterization was performed with use of coaxial technique into the third-order branch of the feeding hepatic artery. Under fluoroscopy, 1-4 mL of 75% ethanol mixed with iodized oil was infused.
RESULTS: Complete segmental or subsegmental devascularization of the feeding arteries and tumor vascularities occurred in all patients. Follow-up CT or angiography after 9-37 months revealed decrease of tumor in six of nine nonsurgical cases. Subsequent segmentectomy or tumorectomy in five patients revealed total or near-total necrosis of the tumor and thickening of capsules, explaining the halo seen around the tumor on CT scans and the relatively intact surrounding parenchyma seen microscopically.
CONCLUSION: Superselective transcatheter arterial embolization with ethanol and iodized oil is a safe method for treatment of small nodular hepatocellular carcinoma with a prominent feeding artery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390316     DOI: 10.1016/s1051-0443(93)71869-2

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  8 in total

1.  Segmental embolization by ethanol iodized oil emulsion for hepatocellular carcinoma.

Authors:  X Li; G Hu; P Liu
Journal:  J Tongji Med Univ       Date:  1999

2.  Therapeutic effects of transarterial infusion of lipiodol and ethanol in various ratios in a rabbit VX2 tumor model.

Authors:  Feng Gao; Ting Qian; Mao Zhen Chen; Hua Bin Yin; Ya Li Xu
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

3.  Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-lipiodol mixture in treating hepatocellular carcinoma.

Authors:  Yun-Chung Cheung; Sheung-Fat Ko; Shu-Hang Ng; Siu-Cheung Chan; Yu-Fan Cheng
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

4.  Transcatheter arterial embolization of renal VX-2 carcinoma: ethiodol-ethanol capillary embolization combined with carboplatin.

Authors:  András Kónya; Byung Gil Choi; Carolyn S Van Pelt; Kenneth C Wright
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

5.  Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?

Authors:  Francesco Somma; Roberto D'Angelo; Nicola Serra; Gianluca Gatta; Roberto Grassi; Francesco Fiore
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

6.  Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Authors:  Biao Yang; Xin You; Min Lan Yuan; Tian Qiang Qin; Lin Jia Duan; Jiao He; Ze Jun Fei; Xuan Zhou; Rui Yu Zan; Zheng Yin Liao
Journal:  Hepat Mon       Date:  2016-07-23       Impact factor: 0.660

7.  Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus.

Authors:  Biao Yang; Chun-Lin Li; Wen-Hao Guo; Tian-Qiang Qin; He Jiao; Ze-Jun Fei; Xuan Zhou; Lin-Jia Duan; Zheng-Yin Liao
Journal:  BMC Cancer       Date:  2018-01-29       Impact factor: 4.430

Review 8.  Identifying the Best Anticancer Agent Combination in TACE for HCC Patients: A Network Meta-analysis.

Authors:  Tao Guo; Ping Wu; Pengpeng Liu; Baiyang Chen; Xiang Jiang; Yang Gu; Zhisu Liu; Zhen Li
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.